Patients' diagnosis decisions in Alzheimer's disease: The influence of family factors

Social Science and Medicine

Volumn 118, Issue C, 2014, Pages 9-16

  Rapp, Thomas ^a  

^a et Institut de recherche et documentation en économie de la santé   (France)

Author keywords

Diagnosis; France; Informal care; Information

Indexed keywords

HEALTH CARE; HISTORY; INFORMATION; MENTAL HEALTH;

AGED; ALZHEIMER DISEASE; ARTICLE; CAREGIVER; CONTROLLED STUDY; DELAYED DIAGNOSIS; FAMILY HISTORY; FEMALE; FRENCHMAN; HEALTH CARE POLICY; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT DECISION MAKING; QUALITY OF LIFE; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SEX DIFFERENCE; AGE; FAMILY; FRANCE; GENETIC PREDISPOSITION; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; SOCIAL SUPPORT; SOCIOECONOMICS; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; TIME; VERY ELDERLY;

FRANCE;

AGE FACTORS; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CAREGIVERS; FAMILY; FEMALE; FRANCE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MODELS, ECONOMIC; QUALITY OF LIFE; SEX FACTORS; SOCIAL SUPPORT; SOCIOECONOMIC FACTORS; TIME FACTORS;

EID: 84927127779     PISSN: 02779536     EISSN: 18735347     Source Type: Journal    
DOI: 10.1016/j.socscimed.2014.07.052     Document Type: Article

References (41)

1. Andersson H., Lundborg P. Perception of own death risk. An analysis of road-traffic and overall mortality risks. J.Risk Uncertain. 2007, 34:67-84.
2. Barber B., Odean T. Boys will be boys: gender, overconfidence, and common stock investment. Q.J. Econ. 2001, 116:261-292.
3. Berger L., Bleichrodt H., Eeckhoudt L. Treatment decisions under ambiguity. J.Health Econ. 2013, 32:559-569.
4. Bernasek A., Shwiff S. Gender, risk, and retirement. J.Econ. Issues 2001, 35:345-356.
5. Brant R. Assessing proportionality in the proportional odds model for ordered logistic regression. Biometrics 1990, 46:1171-1178.
6. Breslow N.E. Ageneralized Kruskal-Wallis test for comparing K samples subject to unequal patterns of censorship. Biometrika 1970, 57:579-594.
7. Carpentier N., Bernard P., Grenier A., Guberman N. Using the life course perspective to study the entry into the illness trajectory: the perspective of caregivers of people with Alzheimer's disease. Soc. Sci. Med. 2010, 70:1501-1508.
8. Clare L. Managing threats to self: awareness in early stage Alzheimer's disease. Soc. Sci. Med. 2003, 57:1017-1029.
9. Clare L., Rowlands J., Bruce E., Surr C., Downs M. 'I don't do like I used to do': a grounded theory approach to conceptualising awareness in people with moderate to severe dementia living in long-term care. Soc. Sci. Med. 2008, 66:2366-2377.
10. Cohen M., Etner J., Jeleva M. Dynamic decision making when risk perception depends on past experience. Theory Decis. 2008, 64:173-192.
11. Dartigues J.F. Alzheimer's disease: early diagnosis. Rev. Prat. 2011, 61:926-930.
12. David G., Saynisch P., Acevedo-Perez V., Neuman M.D. Affording to wait: medicare initiation and the use of health care. Health Econ. 2012, 21:1030-1036.
13. Eeckhoudt L.R., Lebrun T.C., Sailly J.C. The informative content of diagnostic tests: an economic analysis. Soc. Sci. Med. 1984, 18:873-880.
14. Ellsberg D. Risk, ambiguity, and the Savage axioms. Q.J. Econ. 1961, 75:643-669.
15. Etner J., Jeleva M. Risk perception, prevention and diagnostic tests. Health Econ. 2013, 22:144-156.
16. Fillit H., Cummings J., Neumann P., McLaughlin T., Salavtore P., Leibman C. Novel approaches to incorporating pharmacoeconomic studies into phase III clinical trials for Alzheimer's disease. J.Nutr. Health Aging 2010, 640-647.
17. Ganz M.L. Family health effects: complements or substitutes. Health Econ. 2001, 10:699-714.
18. Gehan E.A. Ageneralized Wilcoxon test for comparing arbitrarily singly censored samples. Biometrika 1965, 52:203-223.
19. Graham C., Higuera L., Lora E. Which health conditions cause the most unhappiness?. Health Econ. 2011, 20:1431-1447.
20. Hansen E.C., Hughes C., Routley G., Robinson A.L. General practitioners' experiences and understandings of diagnosing dementia: factors impacting on early diagnosis. Soc. Sci. Med. 2008, 67:1776-1783.
21. HAS Diagnostic et prise en charge de la maladie d'Alzheimer et des maladies apparentées: recommandation 71 2011, Haute Autorité de Santé, Saint-Denis.
22. Hutchinson S.A., Leger-Krall S., Wilson H.S. Early probable Alzheimer's disease and awareness context theory. Soc. Sci. Med. 1997, 45:1399-1409.
23. Kaplan E.L., Meier P. Nonparametric estimation for incomplete observations. J.Am. Stat. Assoc. 1958, 53:457-481.
24. Kivela P.S., Krol A., Salminen M.O., Ristola M.A. Determinants of late HIV diagnosis among different transmission groups in Finland from 1985 to 2005. HIV Med. 2010, 11:360-367.
25. Koszegi B. Health anxiety and patient behavior. J.Health Econ. 2003, 22:1073-1084.
26. Lin P.J., Cangelosi M.J., Lee D.W., Neumann P.J. Willingness to pay for diagnostic technologies: a review of the contingent valuation literature. Value Health 2013, 16:797-805.
27. Logsdon R.G., Gibbons L.E., McCurry S.M., Teri L. Assessing quality of life in older adults with cognitive impairment. Psychosom. Med. 2002, 64:510-519.
28. Low L.F., Anstey K.J. The public's perception of the plausibility of dementia risk factors is not influenced by scientific evidence. Dement. Geriatr. Cogn. Disord. 2007, 23:202-206.
29. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
30. Meechan G., Collins J., Petrie K. Delay in seeking medical care for self-detected breast symptoms in New Zealand women. N.Z. Med. J. 2002, 115:U257.
31. Neumann P.J., Cohen J.T., Hammitt J.K., Concannon T.W., Auerbach H.R., Fang C., et al. Willingness-to-pay for predictive tests with no immediate treatment implications: a survey of US residents. Health Econ. 2012, 21:238-251.
32. Neumann P.J., Hammitt J.K., Mueller C., Fillit H.M., Hill J., Tetteh N.A., et al. Public attitudes about genetic testing for Alzheimer's disease. Health Aff. (Millwood) 2001, 20:252-264.
33. Nourhashemi F., Andrieu S., Gillette-Guyonnet S., Giraudeau B., Cantet C., Coley N., et al. Effectiveness of a specific care plan in patients with Alzheimer's disease: cluster randomised trial (PLASA study). BMJ 2010, 340:c2466.
34. Nourhashemi F., Gillette-Guyonnet S., Andrieu S., Rolland Y., Ousset P.J., Vellas B. Arandomized trial of the impact of a specific care plan in 1120 Alzheimer's patients (PLASA Study) over a two-year period: design and baseline data. J.Nutr. Health Aging 2008, 12:263-271.
35. Plan-Alzheimer Plan Alzheimer 2008-2012 2012.
36. Rapp T., Andrieu S., Molinier L., Grand A., Cantet C., Mullins C.D., et al. Exploring the relationship between Alzheimer's disease severity and longitudinal costs. Value Health 2012, 15:412-419.
37. Slovic P. The Perception of Risk 2000, Earthscan Publications Ltd, London and Sterling.
38. TNS-SOFRES Les français face à l'anticipation de la maladie d'Alzheimer 2013, TNS SOFRES, Paris. T. SOFRES (Ed.).
39. Viscusi W., Magat W., Huber J. Communication of ambiguous risk information. Theory Decis. 1991, 31:159-173.
40. Walsh B., Silles M., O'Neill C. The role of private medical insurance in socio-economic inequalities in cancer screening uptake in Ireland. Health Econ. 2012, 21:1250-1256.
41. Wimo A., von Strauss E., Nordberg G., Sassi F., Johansson L. Time spent on informal and formal care giving for persons with dementia in Sweden. Health Policy 2002, 61:255-268.